2 November 2015 - Edoxaban tosylate (Lixiana) has considerable additional benefit when compared to vitamin K antagonists for the prevention of stroke and systolic embolism in patients with non-valvular atrial fibrillation.

For more details, go to: https://www.iqwig.de/de/presse/pressemitteilungen/pressemitteilungen/edoxaban-betrachtlicher-zusatznutzen-fur-bestimmte-patienten.7001.html?&et_cid=4&et_lid=%25208 [German]